How it works:
Video: Ekso Bionics Killed by Naked Short Sellers – Is HCWainwright Culpable for Front-Running Their Death?
VideoArticle: Ekso’s Q4 pre-announcement ‘bodes well’ for 2020 growth, says H.C. Wainwright
Article - MediaEkso’s Q4 pre-announcement ‘bodes well’ for 2020 growth, says H.C. Wainwright
TheFly, 10 January 2020
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $1.20 price target on Ekso Bionics, saying the pre-announced “record” fourth quarter “bodes well” for continued growth in 2020.
Comment: This appears to be a stellar example of a life-saving vital technology company being destroyed by collusion between a placement agent and naked short sellers.
RELATED:
Article: Ekso Bionics Announces Closing of $5.0 Million Registered Direct Offering
Article - MediaEkso Bionics Announces Closing of $5.0 Million Registered Direct Offering
GlobeNewswire, 20 December 2019
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the closing of its previously announced registered direct offering of 11,111,116 shares of its common stock and warrants to purchase up to 8,333,337 shares of its common stock, at a combined purchase price of $0.45 per share and associated warrant, for aggregate gross proceeds of approximately $5.0 million.
Comment: This appears to be a stellar example of a life-saving vital technology company being destroyed by collusion between a placement agent and naked short sellers.
RELATED:
Article: H.C. WAINWRIGHT STICKS TO ITS BUY RATING FOR EKSO BIONICS (EKSO)
Article - MediaH.C. WAINWRIGHT STICKS TO ITS BUY RATING FOR EKSO BIONICS (EKSO)
Catie Powers
Markets.co, 31 October 2019
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a rating on EKSO BIONICS ( – Research Report) today and set a price target of $1.20. The company’s shares closed last Monday at $0.66, close to its 52-week low of $0.48.
Comment: This company is at risk of collusion between a placement agent and naked short sellers.
RELATED:
Article: H.C. Wainwright Starts Ekso Bionics (EKSO) at Buy
Article - MediaH.C. Wainwright Starts Ekso Bionics (EKSO) at Buy
StreetInsider.com, 28 October 2019
H.C. Wainwright analyst Swayampakula Ramakanth initiates coverage on Ekso Bionics (NASDAQ: EKSO) with a Buy rating and a price target of $1.20.
Comment: This appears to be a stellar example of a life-saving vital technology company being destroyed by collusion between a placement agent and naked short sellers.
RELATED:
Article: H.C. Wainwright Initiates Coverage On Ekso Bionics Holdings with Buy Rating, Announces $1.2 Price Target
Article - MediaBenzinga, 1 October 2019
Comment: This appears to be a stellar example of a life-saving vital technology company being destroyed by collusion between a placement agent and naked short sellers.
RELATED:
Article: How to Handle a Short Attack on a Stock You Own
Article - MediaHow to Handle a Short Attack on a Stock You Own
Keith Fitz-Gerald
TotalWealth, 3 June2015
An anonymous individual writing under the name “The Pump Stopper” launched a vicious attack on Ekso Bionics Holdings Inc. (OTC:EKSO) yesterday that immediately pressured the stock and caused it to drop 24.28% to close at $1.36 a share on heavy volume. Understandably, that makes a lot of people nervous.
Comment: This appears to be a stellar example of a life-saving vital technology company being destroyed by collusion between a placement agent and naked short sellers.
